Figure 1. Liquid biopsy approaches for cancer detection. Cell-free DNA technologies evaluating mutations or methylation are often costly, multistep, time consuming processes prior to data analyses. Low-coverage whole-genome sequencing approaches can minimize arduous laboratory protocols at low-cost with broadly applicable bioinformatic pipelines. cfDNA, cell-free DNA; MAF, mutant allele frequency.